FDA halts im­ports of sev­er­al Sun Phar­ma drugs made in In­dia due to out­stand­ing qual­i­ty is­sues

A drug man­u­fac­tur­ing site that has gar­nered a lot of at­ten­tion from the FDA this year has been hand­ed an im­port alert from the US reg­u­la­tor, block­ing cer­tain drugs from en­ter­ing the coun­try.

Ac­cord­ing to the FDA, Sun Phar­ma’s plant in the city of Halol, In­dia has been giv­en an im­port alert, as of yes­ter­day, which means that the reg­u­la­tor has enough ev­i­dence to de­tain prod­ucts with­out ex­am­i­na­tion and refuse their en­try in­to the US mar­ket un­til the is­sues are cor­rect­ed and the fa­cil­i­ty is com­pli­ant with cGMP.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.